Clinical trial
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
NCT02813486 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
- Lead sponsor
- Green Cross Corporation
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- June 30, 2016
- Completion date
- November 30, 2016
- Enrollment
- 220 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.